ARZERRA 20 mg/mL (Ofatumumab INJECTION, SOLUTION) 20 mg/mL

ARZERRA 20 mg/mL is an intravenous solution containing ofatumumab, used for specific therapeutic purposes. This medication is designed to target certain conditions, offering a targeted approach to treatment.

Strength

20 mg/mL

Pack Size

50 mL in 1 VIAL, SINGLE-USE (0078-0690-61)

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ARZERRA 20 mg/mL, containing the active ingredient ofatumumab, is primarily used in the management of certain hematologic conditions. It is often prescribed for conditions that require targeted therapy, aiming to address specific cellular mechanisms. Patients may wonder, 'What is ARZERRA used for?' This medication is typically utilized in scenarios where other treatments may not be as effective, providing an alternative for those in need.

Side Effects

When administered, ARZERRA 20 mg/mL may cause common effects such as infusion reactions, fatigue, and fever. These effects can vary among individuals and are generally managed with appropriate medical supervision. It is important for patients to discuss any concerns about potential effects with their healthcare provider.

Precautions & Warnings

ARZERRA 20 mg/mL should be handled with care, ensuring proper storage and administration protocols are followed. It is crucial to use this medication under the guidance of a healthcare professional to minimize risks. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment.

Avoid Interactions

ARZERRA 20 mg/mL may interact with certain medications, including those that affect the immune system. It is important to disclose all current medications to a healthcare provider to avoid potential interactions. Alcohol and other substances may also impact the effectiveness and safety of this medication.

Frequently Asked Questions

ARZERRA is used in the treatment of certain hematologic conditions, providing a targeted approach to therapy.

ARZERRA is administered intravenously, typically in a clinical setting under medical supervision.

Common effects may include infusion reactions, fatigue, and fever, which should be discussed with a healthcare provider.

ARZERRA may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Precautions include proper storage, administration under medical supervision, and informing the healthcare provider about existing conditions or allergies.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.